$RNAC stock has now risen 22% today, according to our price data from Polygon. There has been approximately $4,566,688 of trading volume.
Here is what we see in our data on $RNAC (you can track the company live on Quiver's $RNAC stock page):
$RNAC Insider Trading Activity
$RNAC insiders have traded $RNAC stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RNAC stock by insiders over the last 6 months:
- TIMOTHY C BARABE purchased 30,000 shares for an estimated $205,797
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RNAC Hedge Fund Activity
We have seen 29 institutional investors add shares of $RNAC stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MPM BIOIMPACT LLC removed 306,007 shares (-44.6%) from their portfolio in Q3 2025, for an estimated $3,127,391
- FMR LLC removed 178,341 shares (-7.6%) from their portfolio in Q3 2025, for an estimated $1,822,645
- CITADEL ADVISORS LLC removed 50,350 shares (-41.7%) from their portfolio in Q3 2025, for an estimated $514,577
- GSA CAPITAL PARTNERS LLP added 44,493 shares (+106.9%) to their portfolio in Q3 2025, for an estimated $454,718
- XTX TOPCO LTD added 26,259 shares (+inf%) to their portfolio in Q3 2025, for an estimated $268,366
- MILLENNIUM MANAGEMENT LLC added 25,357 shares (+inf%) to their portfolio in Q3 2025, for an estimated $259,148
- BRIDGEWAY CAPITAL MANAGEMENT, LLC added 25,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $255,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RNAC Analyst Ratings
Wall Street analysts have issued reports on $RNAC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/19/2025
- BTIG issued a "Buy" rating on 11/14/2025
- Wedbush issued a "Outperform" rating on 07/09/2025
To track analyst ratings and price targets for $RNAC, check out Quiver Quantitative's $RNAC forecast page.
$RNAC Price Targets
Multiple analysts have issued price targets for $RNAC recently. We have seen 3 analysts offer price targets for $RNAC in the last 6 months, with a median target of $38.0.
Here are some recent targets:
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $30.0 on 11/19/2025
- Julian Harrison from BTIG set a target price of $44.0 on 11/14/2025
- Martin Fan from Wedbush set a target price of $38.0 on 07/09/2025
You can track data on $RNAC on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
